Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I

Takeshi Sato; Mikako Inokuchi; Satsuki Nakano; Yu Iwabuchi; Tetsu Hayashida; Tomohiro Ishii; Tomonobu Hasegawa

doi:10.1016/j.radcr.2022.09.084

Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I

Takeshi Sato, Mikako Inokuchi, Satsuki Nakano, Yu Iwabuchi, Tetsu Hayashida, Tomohiro Ishii, Tomonobu Hasegawa

Research output: Contribution to journal › Article › peer-review

Abstract

A 43-year-old woman with genetically confirmed glycogen storage disease type Ib was suspected to have left breast cancer. Fluorodeoxyglucose-positron emission tomography showed high fluorodeoxyglucose accumulation in the whole liver as well as left mammary gland. We consider that high fluorodeoxyglucose accumulation in the liver of patients with glycogen storage disease type I is caused by impaired glucose-6-phosphate metabolism due to the congenital deficiency of glucose-6-phosphatase activities in hepatocytes. This study describes fluorodeoxyglucose-positron emission tomography as a potential alternative tool to diagnose glycogen storage disease type I functionally.

Original language	English
Pages (from-to)	91-93
Number of pages	3
Journal	Radiology Case Reports
Volume	18
Issue number	1
DOIs	https://doi.org/10.1016/j.radcr.2022.09.084
Publication status	Published - 2023 Jan

Keywords

Fluorodeoxyglucose-positron emission tomography
Functional diagnosis
Glycogen storage disease type I

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.radcr.2022.09.084

Cite this

@article{b7675d9baf434546ab100c0e7108847e,

title = "Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I",

abstract = "A 43-year-old woman with genetically confirmed glycogen storage disease type Ib was suspected to have left breast cancer. Fluorodeoxyglucose-positron emission tomography showed high fluorodeoxyglucose accumulation in the whole liver as well as left mammary gland. We consider that high fluorodeoxyglucose accumulation in the liver of patients with glycogen storage disease type I is caused by impaired glucose-6-phosphate metabolism due to the congenital deficiency of glucose-6-phosphatase activities in hepatocytes. This study describes fluorodeoxyglucose-positron emission tomography as a potential alternative tool to diagnose glycogen storage disease type I functionally.",

keywords = "Fluorodeoxyglucose-positron emission tomography, Functional diagnosis, Glycogen storage disease type I",

author = "Takeshi Sato and Mikako Inokuchi and Satsuki Nakano and Yu Iwabuchi and Tetsu Hayashida and Tomohiro Ishii and Tomonobu Hasegawa",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2023",

month = jan,

doi = "10.1016/j.radcr.2022.09.084",

language = "English",

volume = "18",

pages = "91--93",

journal = "Radiology Case Reports",

issn = "1930-0433",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I

AU - Sato, Takeshi

AU - Inokuchi, Mikako

AU - Nakano, Satsuki

AU - Iwabuchi, Yu

AU - Hayashida, Tetsu

AU - Ishii, Tomohiro

AU - Hasegawa, Tomonobu

PY - 2023/1

Y1 - 2023/1

N2 - A 43-year-old woman with genetically confirmed glycogen storage disease type Ib was suspected to have left breast cancer. Fluorodeoxyglucose-positron emission tomography showed high fluorodeoxyglucose accumulation in the whole liver as well as left mammary gland. We consider that high fluorodeoxyglucose accumulation in the liver of patients with glycogen storage disease type I is caused by impaired glucose-6-phosphate metabolism due to the congenital deficiency of glucose-6-phosphatase activities in hepatocytes. This study describes fluorodeoxyglucose-positron emission tomography as a potential alternative tool to diagnose glycogen storage disease type I functionally.

AB - A 43-year-old woman with genetically confirmed glycogen storage disease type Ib was suspected to have left breast cancer. Fluorodeoxyglucose-positron emission tomography showed high fluorodeoxyglucose accumulation in the whole liver as well as left mammary gland. We consider that high fluorodeoxyglucose accumulation in the liver of patients with glycogen storage disease type I is caused by impaired glucose-6-phosphate metabolism due to the congenital deficiency of glucose-6-phosphatase activities in hepatocytes. This study describes fluorodeoxyglucose-positron emission tomography as a potential alternative tool to diagnose glycogen storage disease type I functionally.

KW - Fluorodeoxyglucose-positron emission tomography

KW - Functional diagnosis

KW - Glycogen storage disease type I

UR - http://www.scopus.com/inward/record.url?scp=85140782034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140782034&partnerID=8YFLogxK

U2 - 10.1016/j.radcr.2022.09.084

DO - 10.1016/j.radcr.2022.09.084

M3 - Article

AN - SCOPUS:85140782034

SN - 1930-0433

VL - 18

SP - 91

EP - 93

JO - Radiology Case Reports

JF - Radiology Case Reports

IS - 1

ER -

Fluorodeoxyglucose-positron emission tomography as a potential alternative tool for functional diagnosis of glycogen storage disease type I

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this